ISRG

Intuitive Surgical Inc. (ISRG) | Rumor.io

Intuitive Surgical

ISRG

Attention (50-day avg)0.03%

Attention rank (50-day avg)#211

Bullish sentiment (50-day avg)94%

Price to earnings ratio47.5

Market capitalization148.6B

Earnings per share8.71

Dividend yield (TTM)—

Revenue (annual)10.1B

Net income (annual)2.9B

Social

What share of all stock conversation is about ISRG?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0.02% +0	0.04% +0.01	0.03% +0

Sep 24

Intuitive Surgical, Inc. ($ISRG) has maintained its market leadership in robotic-assisted surgery, with a ~70% market share in soft-tissue robotic surgery.
The company's valuation multiple has been affected by emerging competition in its core markets, raising questions about whether the stock's recent decline is a valuation reset or a change in the underlying investment.
$ISRG has formed a bullish double bottom on the weekly chart, with price testing a key technical zone where buyers could step in, and a breakout above the neckline would add confirmation to the setup.

Generated by AI

Sentiment

Of the messages about ISRG that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	71.23% -28.58	89.81% +3.86	91.99% -5.35
Bearish	—	28.77% +28.58	10.19% -3.86	8.01% +5.35

Bullish· Sep 20

Intuitive Surgical ($ISRG) maintains its market monopoly and moat in robotic-assisted surgery, driving structural innovation in healthcare tech.
The company's strong rebound into resistance has bulls in control, with key levels indicating a break above $400 could accelerate momentum.
Intuitive Surgical is poised for a retest of structural pivot levels at $429.00 and $440.10, driven by strong procedure volume expansion and da Vinci 5 adoption.

Bearish· Jul 17

Intuitive Surgical, Inc. ($ISRG) is trading at its cheapest valuation in a decade, which may attract investors but also increases competition in the market.
The company is facing increased competition from Medtronic's Hugo robot, which was recently approved for use, and slowing U.S. procedure growth, which may impact demand.
Recent downgrades and price target cuts from analysts, including Oppenheimer, are adding to the stock's downward pressure, despite a beat in Q2 earnings and revenue.

Generated by AI

Topics

Of the messages about ISRG that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Technical Analysis	—	63.04%	0.51%	1.46%
Macro	—	0%	49.63%	48.79%
Announcements	—	36.96%	0.28%	9.65%
Earnings	—	0%	0.12%	7.54%
Analysts	—	0%	49.45%	32.56%
Controversies	—	0%	0%	0%

Earnings· Jul 17

Intuitive Surgical's Q2 FY2026 earnings report showed revenue up 18%, cost of revenue grew 13%, gross profit grew 21%, and operating income grew 31%.
The company beat Q2 revenue expectations, but domestic growth anxieties and analyst caution weighed on the stock, causing shares to dip despite a strong quarter.
Intuitive Surgical's Q2 2026 earnings were marked by strong revenue and profit growth, with total revenue coming in at $2.89B, non-GAAP EPS jumping 28% to $2.80, and gross margin hitting 70%.

Analysts· Jul 17

Bernstein lowered Intuitive Surgical's price target to $685 from $750, citing another strong quarter financially, but worries about U.S. procedure growth trend will weigh on the stock.
Mizuho lowered Intuitive Surgical's price target to $400 from $500, citing in-line performances across instruments and accessories, linked to a slowdown in da Vinci procedures, and predicting a "healthy sell-off to multi-year lows."
Analysts have lowered Intuitive Surgical's price targets across the board, with Bernstein, Mizuho, Piper Sandler, BTIG, Leerink, Baird, Citi, JPMorgan, and Wells Fargo all reducing their targets, citing concerns over procedure growth, valuation, and the company's ability to maintain its growth momentum.

Announcements· Apr 21

Intuitive Surgical, Inc. ($ISRG) reported Q1 2026 earnings with revenue of $2.77B, a 23% increase year-over-year.
The company's adjusted EPS was $2.50, beating estimates of $2.11, and worldwide procedures grew approximately 17%.
Da Vinci procedure growth was approximately 16%, while Ion procedures grew by 39%, and the company placed 431 da Vinci surgical systems.

Technical Analysis· Jul 19

Intuitive Surgical's ($ISRG) chart shows a major breakdown with a big double top on the weekly chart, making a bottom fish unwise.
The stock has hit key support and bounced off the 355-356 area, but may pin at 380 or higher today, or potentially break down further.
$ISRG's upward trendline has been broken, and a bear flag has formed, suggesting a short position may be a good option.

Generated by AI

Community

Of the messages about ISRG, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	16.67%	51.15%	81.3%	42.39%
Newcomers	83.33%	48.85%	18.7%	57.61%

Regulars· Aug 20

The regulars are focused on the short-term price action of ISRG, with some mentioning potential buying opportunities and others expressing concern about the stock's performance.
There is discussion about the relationship between ISRG and PRCT, with some suggesting that ISRG could acquire PRCT's products and successfully integrate them into their own offerings.
The regulars are also tracking ISRG's technical indicators, such as the TRIX cross and MACD, and are using these to inform their trading decisions.

Newcomers· Sep 19

Intuitive Surgical has created a new market in robotic-assisted soft-tissue surgery, with over 20.4 million patients treated on its systems and an installed base exceeding.
The company's revenue split is 59.8% from Instruments and Accessories, 24.6% from Systems, and 15.6% from Service, with a total revenue of $10B in FY25.
The stock price seems expensive to some, with one user hoping it goes down to 300€ again, while another wonders if it's still a good time to consider investing despite the high value.

Generated by AI

News

Top Stock Reports for Visa, Intuitive Surgical & Williams Companies

Visa, Intuitive Surgical and Williams Companies headline today's research, with growth opportunities balanced by margin, valuation and execution risks.

17h agoYahoo Finance Australia

Here is What to Know Beyond Why Intuitive Surgical, Inc. (ISRG) is a Trending Stock

Zacks.com users have recently been watching Intuitive Surgical (ISRG) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

1d agoYahoo Finance

Intuitive Surgical Inc. stock outperforms competitors on strong trading day

1d agoMarketWatch

Gilead vs. Intuitive Surgical: Which Healthcare Stock Offers the Better Risk-Adjusted Upside?

At first glance, Gilead Sciences, Inc. (NASDAQ:GILD) and Intuitive Surgical, Inc. (NASDAQ:ISRG) don’t make for the most obvious comparison. One sells medicines led by a massive HIV franchise, while the other has built its business around robotic surgery. Yet both have given investors a similar reason to pay attention this year, which is that growth […]

1d agoYahoo Finance

Intuitive Surgical Inc. stock outperforms competitors on strong trading day

4d agoMarketWatch

Intuitive expands push into cardiac market with CE mark

After de-emphasizing heart surgery for decades due to limits with its earlier platforms, the surgical robot maker is eyeing the large market in cardiovascular disease treatment.

4d agoYahoo Finance

Also Discussed

Investors talking about ISRG also mention

#	Name	Attention
1	Stryker CorporationSYK	0.01%+0.01
2	ASXC - Asensus Surgical, Inc.	——
3	Medtronic plcMDT	0%+0
4	Boston Scientific Corp.BSX	0.03%-0.02
5	PROCEPT BioRobotics Corp.PRCT	0%0
6	IDEXX Laboratories, Inc.IDXX	0%0
7	Booking Holdings Inc.BKNG	0.02%+0.01
8	Cognex CorpCGNX	0%+0
9	Danaher Corp.DHR	0.02%+0.02
10	F5, Inc.FFIV	0.01%+0.01

Intuitive Surgical Inc.

Healthcare
Medical Instruments & Supplies

Intuitive Surgical Inc. is a medical technology company focused on robotic-assisted and minimally invasive care. Intuitive Surgical develops, manufactures, and markets the da Vinci surgical systems, which are used by surgeons to perform procedures with enhanced precision through a minimally invasive approach. The company also offers the Ion endoluminal system, extending its platform into diagnostic endoluminal procedures and lung biopsy applications. In addition to its core systems, Intuitive Surgical supports hospitals and healthcare providers with instruments, accessories, and services that help integrate robotic surgery into clinical workflows. Its products serve a broad range of specialties, including general surgery, urology, gynecology, thoracic surgery, and diagnostic care. Headquartered in Sunnyvale, California, Intuitive Surgical plays a significant role in the global healthcare equipment market by advancing the adoption of robotic systems in modern surgical and diagnostic settings.

Website

Location

1020 Kifer Road

Sunnyvale, CA, 94086-5304

United States

Social

What share of all stock conversation is about ISRG?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0.02% +0	0.04% +0.01	0.03% +0

Sep 24

Intuitive Surgical, Inc. ($ISRG) has maintained its market leadership in robotic-assisted surgery, with a ~70% market share in soft-tissue robotic surgery.
The company's valuation multiple has been affected by emerging competition in its core markets, raising questions about whether the stock's recent decline is a valuation reset or a change in the underlying investment.
$ISRG has formed a bullish double bottom on the weekly chart, with price testing a key technical zone where buyers could step in, and a breakout above the neckline would add confirmation to the setup.

Generated by AI

Sentiment

Of the messages about ISRG that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	71.23% -28.58	89.81% +3.86	91.99% -5.35
Bearish	—	28.77% +28.58	10.19% -3.86	8.01% +5.35

Bullish· Sep 20

Intuitive Surgical ($ISRG) maintains its market monopoly and moat in robotic-assisted surgery, driving structural innovation in healthcare tech.
The company's strong rebound into resistance has bulls in control, with key levels indicating a break above $400 could accelerate momentum.
Intuitive Surgical is poised for a retest of structural pivot levels at $429.00 and $440.10, driven by strong procedure volume expansion and da Vinci 5 adoption.

Bearish· Jul 17

Intuitive Surgical, Inc. ($ISRG) is trading at its cheapest valuation in a decade, which may attract investors but also increases competition in the market.
The company is facing increased competition from Medtronic's Hugo robot, which was recently approved for use, and slowing U.S. procedure growth, which may impact demand.
Recent downgrades and price target cuts from analysts, including Oppenheimer, are adding to the stock's downward pressure, despite a beat in Q2 earnings and revenue.

Generated by AI

Topics

Of the messages about ISRG that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Technical Analysis	—	63.04%	0.51%	1.46%
Macro	—	0%	49.63%	48.79%
Announcements	—	36.96%	0.28%	9.65%
Earnings	—	0%	0.12%	7.54%
Analysts	—	0%	49.45%	32.56%
Controversies	—	0%	0%	0%

Earnings· Jul 17

Intuitive Surgical's Q2 FY2026 earnings report showed revenue up 18%, cost of revenue grew 13%, gross profit grew 21%, and operating income grew 31%.
The company beat Q2 revenue expectations, but domestic growth anxieties and analyst caution weighed on the stock, causing shares to dip despite a strong quarter.
Intuitive Surgical's Q2 2026 earnings were marked by strong revenue and profit growth, with total revenue coming in at $2.89B, non-GAAP EPS jumping 28% to $2.80, and gross margin hitting 70%.

Analysts· Jul 17

Bernstein lowered Intuitive Surgical's price target to $685 from $750, citing another strong quarter financially, but worries about U.S. procedure growth trend will weigh on the stock.
Mizuho lowered Intuitive Surgical's price target to $400 from $500, citing in-line performances across instruments and accessories, linked to a slowdown in da Vinci procedures, and predicting a "healthy sell-off to multi-year lows."
Analysts have lowered Intuitive Surgical's price targets across the board, with Bernstein, Mizuho, Piper Sandler, BTIG, Leerink, Baird, Citi, JPMorgan, and Wells Fargo all reducing their targets, citing concerns over procedure growth, valuation, and the company's ability to maintain its growth momentum.

Announcements· Apr 21

Intuitive Surgical, Inc. ($ISRG) reported Q1 2026 earnings with revenue of $2.77B, a 23% increase year-over-year.
The company's adjusted EPS was $2.50, beating estimates of $2.11, and worldwide procedures grew approximately 17%.
Da Vinci procedure growth was approximately 16%, while Ion procedures grew by 39%, and the company placed 431 da Vinci surgical systems.

Technical Analysis· Jul 19

Intuitive Surgical's ($ISRG) chart shows a major breakdown with a big double top on the weekly chart, making a bottom fish unwise.
The stock has hit key support and bounced off the 355-356 area, but may pin at 380 or higher today, or potentially break down further.
$ISRG's upward trendline has been broken, and a bear flag has formed, suggesting a short position may be a good option.

Generated by AI

Community

Of the messages about ISRG, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	16.67%	51.15%	81.3%	42.39%
Newcomers	83.33%	48.85%	18.7%	57.61%

Regulars· Aug 20

The regulars are focused on the short-term price action of ISRG, with some mentioning potential buying opportunities and others expressing concern about the stock's performance.
There is discussion about the relationship between ISRG and PRCT, with some suggesting that ISRG could acquire PRCT's products and successfully integrate them into their own offerings.
The regulars are also tracking ISRG's technical indicators, such as the TRIX cross and MACD, and are using these to inform their trading decisions.

Newcomers· Sep 19

Intuitive Surgical has created a new market in robotic-assisted soft-tissue surgery, with over 20.4 million patients treated on its systems and an installed base exceeding.
The company's revenue split is 59.8% from Instruments and Accessories, 24.6% from Systems, and 15.6% from Service, with a total revenue of $10B in FY25.
The stock price seems expensive to some, with one user hoping it goes down to 300€ again, while another wonders if it's still a good time to consider investing despite the high value.

Generated by AI

Intuitive Surgical

Social

Sep 24

Bullish· Sep 20

Bearish· Jul 17

Earnings· Jul 17

Analysts· Jul 17

Announcements· Apr 21

Technical Analysis· Jul 19

Regulars· Aug 20

Newcomers· Sep 19

Top Stock Reports for Visa, Intuitive Surgical & Williams Companies

Here is What to Know Beyond Why Intuitive Surgical, Inc. (ISRG) is a Trending Stock

Intuitive Surgical Inc. stock outperforms competitors on strong trading day

Gilead vs. Intuitive Surgical: Which Healthcare Stock Offers the Better Risk-Adjusted Upside?

Intuitive Surgical Inc. stock outperforms competitors on strong trading day

Intuitive expands push into cardiac market with CE mark

Also Discussed

Intuitive Surgical Inc.

Company Information

Location

Top Stock Reports for Visa, Intuitive Surgical & Williams Companies

Here is What to Know Beyond Why Intuitive Surgical, Inc. (ISRG) is a Trending Stock

Intuitive Surgical Inc. stock outperforms competitors on strong trading day

Gilead vs. Intuitive Surgical: Which Healthcare Stock Offers the Better Risk-Adjusted Upside?

Intuitive Surgical Inc. stock outperforms competitors on strong trading day

Intuitive expands push into cardiac market with CE mark

Also Discussed

Social

Sep 24

Bullish· Sep 20

Bearish· Jul 17

Earnings· Jul 17

Analysts· Jul 17

Announcements· Apr 21

Technical Analysis· Jul 19

Regulars· Aug 20

Newcomers· Sep 19